Literature DB >> 14737959

Incidence of elevated LH/FSH ratio in polycystic ovary syndrome women with normo- and hyperinsulinemia.

B Banaszewska1, R Z Spaczyński, M Pelesz, L Pawelczyk.   

Abstract

PURPOSE: The aim of this study was to determine the incidence of abnormal LH/FSH ratio in women with polycystic ovary with normo- and hyperinsulinemia and to assess the influence of elevated LH/FSH ratio on selected endocrine and biochemical parameters.
MATERIAL AND METHODS: One hundred nineteen polycystic ovary syndrome women in reproductive age hospitalized between 1996 and 2000 in Division of Infertility and Reproductive Endocrinology at Poznan University of Medical Sciences were selected for the study. In all selected women LH and FSH serum levels were determined and LH/FHS ratio was calculated. These groups became the subject of a detailed clinical, hormonal and metabolic analysis, which was performed between 6th and 10th day of a natural or induced menstrual period.
RESULTS: LH/FSH ratio greater than 2 was accepted as abnormal, and it was found in 54 women (45.4%; I group). Normal gonadotropin ratio was detected in 65 women (55%; group II). Statistically significant differences were noted between groups with normal and elevated LH/FSH ratio in the following parameters: BMI (body mass index), serum insulin, and LH levels. Further analysis revealed that the majority of women with elevated insulin concentrations belong to the group with normal LH/FSH ratio.
CONCLUSIONS: LH/FSH ratio is not a characteristic attribute of all PCOS women: in the present study this abnormality was detected in a subpopulation smaller than 50%. Most of the PCOS women with normal gonadotropin ratio belong to a group of patients suffering from hyperinsulinemia and obesity. Patients with hyperinsulinemia and excess of LH constitute a selected and distinct subgroup with increased adrenal androgenic activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14737959

Source DB:  PubMed          Journal:  Rocz Akad Med Bialymst


  32 in total

1.  Significance of pro-angiogenic estrogen metabolites in normal follicular development and follicular growth arrest in polycystic ovary syndrome.

Authors:  Soledad Henríquez; Paulina Kohen; Xia Xu; Claudio Villarroel; Alex Muñoz; Ana Godoy; Jerome F Strauss; Luigi Devoto
Journal:  Hum Reprod       Date:  2020-07-01       Impact factor: 6.918

Review 2.  Neuroendocrine dysfunction in PCOS: a critique of recent reviews.

Authors:  Suhail A R Doi
Journal:  Clin Med Res       Date:  2008-09

3.  Ovarian steroids modulate neuroendocrine dysfunction in polycystic ovary syndrome.

Authors:  S A R Doi; M Al-Zaid; P A Towers; C J Scott; K A S Al-Shoumer
Journal:  J Endocrinol Invest       Date:  2005-11       Impact factor: 4.256

4.  Relationship of obesity-related disturbances with LH/FSH ratio among post-menopausal women in the United States.

Authors:  Hind A Beydoun; May A Beydoun; Natasha Wiggins; Laurel Stadtmauer
Journal:  Maturitas       Date:  2011-11-15       Impact factor: 4.342

Review 5.  Comparison of dietary intake and physical activity between women with and without polycystic ovary syndrome: a review.

Authors:  Annie W Lin; Marla E Lujan
Journal:  Adv Nutr       Date:  2014-09       Impact factor: 8.701

6.  High-fat diet-induced dysregulation of ovarian gene expression is restored with chronic omega-3 fatty acid supplementation.

Authors:  Natalie M Hohos; Emily M Elliott; Kirstin J Cho; Ivy S Lin; Michael C Rudolph; Malgorzata E Skaznik-Wikiel
Journal:  Mol Cell Endocrinol       Date:  2019-10-16       Impact factor: 4.102

7.  ANTIMÜLLERIAN HORMONE AS INDICATOR OF OVARIAN DYSFUNCTION.

Authors:  A Bothou; N Koutlaki; G Iatrakis; G Mastorakos; P Tsikouras; V Liberis; G Galazios; A Liberis; A Lykeridou; S Zervoudis
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Apr-Jun       Impact factor: 0.877

8.  Morphological changes in mouse ovary due to hormonal hypersecretion and matrix metalloproteinase -2 activity.

Authors:  Sang-Hwan Kim; Jong-Taek Yoon
Journal:  Histol Histopathol       Date:  2021-02-23       Impact factor: 2.303

9.  Efficacy of a Novel Fenugreek Seed Extract (Trigonella foenum-graecum, Furocyst) in Polycystic Ovary Syndrome (PCOS).

Authors:  Anand Swaroop; Amrita Sarkari Jaipuriar; Sushil Kumar Gupta; Manashi Bagchi; Pawan Kumar; Harry G Preuss; Debasis Bagchi
Journal:  Int J Med Sci       Date:  2015-10-03       Impact factor: 3.738

10.  Thyroid disorders in polycystic ovarian syndrome subjects: A tertiary hospital based cross-sectional study from Eastern India.

Authors:  Uma Sinha; Keshab Sinharay; Sudipta Saha; T Amenla Longkumer; Shuvra Neel Baul; Salil Kuamr Pal
Journal:  Indian J Endocrinol Metab       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.